We are live on ! Find out more
NKTR icon

Nektar Therapeutics
NKTR

181 hedge funds and large institutions have $1.73B invested in Nektar Therapeutics in 2015 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 23

38% more call options, than puts

Call options by funds: $6.54M | Put options by funds: $4.74M

24% more capital invested

Capital invested by funds: $1.39B → $1.73B (+$338M)

18% more funds holding

Funds holding: 153 → 181 (+28)

18% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 45

Holders
181
Holders Change
+28
Holders Change %
+18.3%
% of All Funds
4.87%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
51
Increased
53
Reduced
45
Closed
23
Calls
$6.54M
Puts
$4.74M
Net Calls
+$1.8M
Net Calls Change
-$2.58M

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$50.7M
2
First Trust Advisors
First Trust Advisors
Illinois
+$39.3M
3
CCM
Camber Capital Management
Massachusetts
+$17.2M
4
GAM
Gotham Asset Management
New York
+$15.6M
5
BA
BlackRock Advisors
Delaware
+$14.1M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$41.1M
2
BIT
BlackRock Institutional Trust
California
-$13.2M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$11.4M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$7.72M
5
DFO
Duquesne Family Office
New York
-$7.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
CLM
101
ClearBridge LLC (Maryland)
Maryland
$832K +$63K +366 +9%
DekaBank Deutsche Girozentrale
102
DekaBank Deutsche Girozentrale
Germany
$799K +$26.3K +153 +4%
LSERS
103
Louisiana State Employees Retirement System
Louisiana
$731K +$670K +3,893 New
1CM
104
1492 Capital Management
Wisconsin
$726K +$173K +1,007 +35%
New York State Teachers Retirement System (NYSTRS)
105
New York State Teachers Retirement System (NYSTRS)
New York
$712K +$653K +3,796 New
PNC Financial Services Group
106
PNC Financial Services Group
Pennsylvania
$683K +$15K +87 +2%
Royal Bank of Canada
107
Royal Bank of Canada
Ontario, Canada
$660K +$49.2K +286 +9%
RFC
108
Russell Frank Company
Washington
$636K +$563K +3,274 +2,897%
Thrivent Financial for Lutherans
109
Thrivent Financial for Lutherans
Minnesota
$626K +$574K +3,333 New
SAM
110
Shell Asset Management
Netherlands
$585K – – –
SEI Investments
111
SEI Investments
Pennsylvania
$575K – – –
PP
112
Paloma Partners
Connecticut
$551K +$506K +2,939 New
DC
113
Deere & Company
Illinois
$550K +$328K +1,905 +186%
Creative Planning
114
Creative Planning
Kansas
$545K +$30.3K +176 +6%
PCM
115
Prelude Capital Management
New York
$534K +$183K +1,066 +60%
QIM
116
Quantitative Investment Management
Virginia
$500K +$459K +2,667 New
KAM
117
Kazazian Asset Management
Florida
$463K +$425K +2,467 New
Public Employees Retirement Association of Colorado
118
Public Employees Retirement Association of Colorado
Colorado
$450K – – –
Barclays
119
Barclays
United Kingdom
$443K -$364K -2,114 -46%
QI
120
QS Investors
New York
$420K – – –
PA
121
Profund Advisors
Maryland
$403K +$369K +2,146 New
SCM
122
Stevens Capital Management
Pennsylvania
$389K +$357K +2,073 New
NSEDCP
123
NJ State Employees Deferred Compensation Plan
New Jersey
$375K – – –
Susquehanna International Group
124
Susquehanna International Group
Pennsylvania
$358K -$608K -3,533 -65%
AIM
125
Ada Investment Management
New York
$322K +$295K +1,716 New
3 4
5
6 7

NKTR Hedge Fund Activity: Q2 2015 in Review

181 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Nektar Therapeutics (NKTR) for Q2 2015, worth a combined $1.73B — up 24% from $1.39B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new NKTR positions and 23 closed out — a net gain of 28 holders — while 53 added to existing stakes and 45 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $50.7M. The largest seller was JP Morgan Chase, cutting an estimated $41.1M.

  • 181 institutional investors held Nektar Therapeutics (NKTR) as of Q2 2015, up from 153 in Q1 2015.
  • Funds reported $1.73B of Nektar Therapeutics stock for Q2 2015, up 24% quarter-over-quarter.
  • 51 funds opened new Nektar Therapeutics positions in Q2 2015 and 23 closed out, a net change of +28 holders.
  • The largest Nektar Therapeutics buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $50.7M added.
  • The largest Nektar Therapeutics seller in Q2 2015 was JP Morgan Chase, an estimated $41.1M sold.

Based on aggregated 13F filings for Q2 2015.